2023-12-14 | Sale | Xenon Pharmaceuticals Inc. XENE | director | 7,598 0.0103% | $41.05 | $311,898 | +4.34% | |
2023-12-13 | Sale | Xenon Pharmaceuticals Inc. XENE | director | 18,978 0.0257% | $39.99 | $758,983 | +7.89% | |
2022-11-25 | Sale | Xenon Pharmaceuticals Inc. XENE | director | 1,937 0.0032% | $34.79 | $67,390 | +8.16% | |
2017-08-10 | Xenon Pharmaceuticals Inc. XENE | director | 15,000 0.0842% | $2.78 | $41,672 | +28.18% | ||
2017-08-08 | Xenon Pharmaceuticals Inc. XENE | director | 10,000 0.0575% | $3.00 | $30,005 | +15.95% | ||
2014-08-07 | Sale | Pacira BioSciences, Inc. PCRX | Chief Medical Officer | 40,000 0.1121% | $100.26 | $4.01M | -7.25% | |
2014-07-14 | Sale | Pacira BioSciences, Inc. PCRX | Chief Medical Officer | 59,400 0.1629% | $86.96 | $5.17M | +5.09% | |
2014-05-12 | Sale | Pacira BioSciences, Inc. PCRX | Chief Medical Officer | 20,000 0.0547% | $75.00 | $1.5M | +20.17% | |
2014-05-09 | Sale | Pacira BioSciences, Inc. PCRX | Chief Medical Officer | 40,000 0.1137% | $74.08 | $2.96M | +26.39% | |
2013-10-01 | Sale | Pacira BioSciences, Inc. PCRX | Chief Medical Officer | 40,000 0.059% | $25.27 | $1.01M | +41.38% | |
2013-07-02 | Sale | Pacira BioSciences, Inc. PCRX | Chief Medical Officer | 20,000 0.0599% | $30.00 | $600,000 | +88.3% | |
2013-07-01 | Sale | Pacira BioSciences, Inc. PCRX | Chief Medical Officer | 60,000 0.1791% | $29.25 | $1.75M | +92.36% | |
2013-04-12 | Sale | Pacira BioSciences, Inc. PCRX | Chief Medical Officer | 20,000 0.0319% | $15.80 | $316,100 | +64.96% | |
2013-04-01 | Sale | Pacira BioSciences, Inc. PCRX | Chief Medical Officer | 60,000 0.1788% | $28.15 | $1.69M | +67.16% |